Active Stocks
Fri Apr 19 2024 09:35:45
  1. Tata Steel share price
  2. 160.50 0.31%
  1. Infosys share price
  2. 1,390.45 -2.12%
  1. Tata Motors share price
  2. 958.75 -1.30%
  1. ITC share price
  2. 423.05 0.98%
  1. NTPC share price
  2. 350.75 -0.18%
Business News/ Markets / Stock Markets/  Stocks to Watch: RIL, HDFC, Maruti, Wipro, Yes Bank, Tata Motors, Adani group
BackBack

Stocks to Watch: RIL, HDFC, Maruti, Wipro, Yes Bank, Tata Motors, Adani group

HDFC, Britannia Industries, Alembic Pharmaceuticals, Adani Wilmar, Castrol India, Devyani International, IDBI Bank, Inox Leisure, JBM Auto, Jindal Stainless, Mahindra & Mahindra Financial Services, Meghmani Organics, are among the key companies scheduled to announce their earnings today

On Friday, the benchmark Sensex fell 460 points to close at closed at 57,060.87, led by losses in banking, IT, and energy shares. The Nifty tanked 142.50 points to end the day at 17,102.55.Premium
On Friday, the benchmark Sensex fell 460 points to close at closed at 57,060.87, led by losses in banking, IT, and energy shares. The Nifty tanked 142.50 points to end the day at 17,102.55.

NEW DELHI: Following are the stocks that could be in focus on Monday: 

Reliance Industries: Is looking to build a mega land bank to set up renewable energy parks and projects, as the Mukesh Ambani-controlled conglomerate pivots from fossil fuels to clean energy. A land aggregation exercise is underway to set up solar power projects of 100GW by 2030.

HDFC: The mortgage lender on Sunday raised its benchmark retail prime lending rate (RPLR) by 5 basis points (bps), leading to an identical hike in home loan rates for existing customers. However, there will be no change in interest rates for new customers as they will get an additional discount of 5 bps on the benchmark, negating the hike in RPLR. HDFC will also announce its March quarter earnings today.

Maruti Suzuki: The country's largest carmaker Maruti Suzuki India has reported a 6% year-on-year decline in total wholesales to 1,50,661 units in April. Last month, Maruti's domestic sales slipped 7% on year to 1,32,248 units. The company posted a 51.1% year-on-year jump in consolidated net profit to 1,875.8 crore in the fourth quarter ended on March, despite chip shortages hampering production. Total revenue from operations stood at 26,749.2 crore as against 24,034.5 crore in the fourth quarter a year ago.

Wipro: Reported a 3.1% sequential rise in its dollar revenue to $2,721.7 million for the quarter ended March, while revenue in constant currency grew 3.1%. Wipro has guided for 1-3% sequential growth in Q1FY23 revenue at $2,748 million to $2,803 million. Profit during the March quarter rose 3.98% sequentially to 3,087.3 crore and revenue rose 2.68% to 20,860 crore.

Tata Motors: The company reported a 74% year-on-year jump in its total sales in April to 72,468 units. Tata Motors' domestic sales surged 81% on year to 71,467 units last month, while total passenger vehicle dispatches to dealers rose 66% to 41,587 units.

Adani group: Is lining up massive investments in the healthcare sector and may acquire large hospitals, diagnostic chains, and offline and digital pharmacies, among other assets, to establish a foothold in the sector. Top executives of the group, which runs businesses ranging from airports to seaports, recently met several foreign banks and global private equity investors, where they outlined the group’s plans in the healthcare business.

IndusInd Bank: Reported a 55.4% year-on-year rise in profit to 1,361.4 crore for the quarter ended March, as provisions declined 21.5% and asset quality improved. Net interest income grew 12.7 percent on year to 3,985.16 crore in Q4.

Yes Bank: The lender’s plan to set up an asset reconstruction company is on track and it expects to transfer all its bad loans to the entity by end of June. As on 31 March, Yes Bank's gross bad loans stood at 27,976 crore. The bank posted a net profit of 367 crore for the March quarter, as against a loss of 3,788 crore a year ago.

Biocon: Subsidiary Biocon Biologics said it can close the transaction of $3.34 billion Viatris' biosimilar business acquisition by as early as this quarter, if it gets a nod from regulatory agencies. In March, Biocon Biologics entered into a definitive agreement to acquire Viatris' biosimilars assets for $3.34 billion. The company will pay Viatris $2 billion in cash at the closing of the deal, and another $335 million in 2024.

Jet Airways: The airline, under its new promoters, will operate proving flights during the first half of May, as it is set to launch its commercial operations in the July-September quarter. During proving flights, or test flights, the airline’s staff, including those at the check-in-counter, engineers, pilots, cabin crew, and maintenance technicians follow activities mirroring real-time commercial operations.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 02 May 2022, 07:59 AM IST
Next Story footLogo
Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started
Switch to the Mint app for fast and personalized news - Get App